A Phase - IIa - IIb, Trial to Study the Safety, Tolerability and Efficacy of Memantine as a Long-term Treatment of SCD
Clinical trial NCT03247218 · UNKNOWN
Trial details
- NCT number
- NCT03247218
- Sponsor
- HaEmek Medical Center, Israel
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-02-02
- Primary completion
- 2020-12-31
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.